Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alvopem® (Pemetrexed) Safety Assessment in Patients With Non-small Cell Lung Cancer and Malignant Pleural Mesothelioma

NCT04843007 is registered in ClinicalTrials.gov with NanoAlvand as lead sponsor.

NCT NCT04843007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04843007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alvopem® (Pemetrexed) Safety Assessment in Patients With Non-small Cell Lung Cancer and Malignant Pleural Mesothelioma
Lead sponsor
NanoAlvand
Phase
Observational
Overall status
Completed
Start date
March 15, 2016
Completion date
January 22, 2020
Enrollment
199 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant pleural mesothelioma, non small cell lung cancer